Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 210 publications
Older Age, STAG2, and DNMT3A Mutations Predict Superior Posttransplant Survival in Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax Plus Hypomethylating Agents.
Journal: American journal of hematology
Published: July 11, 2026
Determinants of survival after failure of frontline venetoclax plus hypomethylating agent therapy in 356 patients with newly diagnosed acute myeloid leukemia.
Journal: Blood cancer journal
Published: May 27, 2026
Acute Myeloid Leukemia Subtype-Specific Prognostic Value of NGS in the Setting of Intensive Chemotherapy.
Journal: American journal of hematology
Published: May 13, 2026
Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents.
Journal: American journal of hematology
Published: May 12, 2026
Local disease control in patients with Erdheim-Chester disease treated with external beam radiation therapy.
Journal: British journal of haematology
Published: April 24, 2026
Risk-Adjusted Comparison of Survival in Chronic Myelomonocytic Leukemia With and Without Allogeneic Stem Cell Transplant: Mayo Clinic Experience in 775 Consecutive Patients.
Journal: American journal of hematology
Published: March 30, 2026
Characteristics of clonal cytopenia of undetermined significance in the presence of ZRSR2 mutations.
Characteristics of clonal cytopenia of undetermined significance in the presence of ZRSR2 mutations.
Journal: Haematologica
Published: February 26, 2026
Dynamic-EASIX DRI Model: A Novel Tool for Predicting Outcomes After Allogeneic Hematopoietic Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: February 08, 2026
Applicability of Allogeneic Hematopoietic Cell Transplant for TP53-Mutated Myeloid Neoplasms: Are We There Yet?
Journal: Transplantation and cellular therapy
Published: February 01, 2026
Characteristics and outcomes of secondary hematological malignancies following autologous stem cell transplantation for multiple myeloma.
Journal: Blood cancer journal
Published: January 15, 2026
Mutational profiling links biologically relevant variants to multisystemic Rosai-Dorfman disease.
Journal: Blood advances
Published: December 01, 2025
Last Updated: 09/26/2026